ஸ்டீபன் வில்லி ஸ்டிபேல் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from ஸ்டீபன் வில்லி ஸ்டிபேல். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In ஸ்டீபன் வில்லி ஸ்டிபேல் Today - Breaking & Trending Today

Compugen Ltd. (CGEN) Q1 2021 Earnings Call Transcript


Operator
Ladies and gentlemen, thank you for joining us today. Welcome to Compugen s First Quarter 2021 Results Conference Call. [Operator Instructions] With us from Compugen are Dr. Anat Cohen-Dayag; Ari Krashin, CFO and COO; and Dr. Henry Adewoye, Chief Medical Officer, who will be available for questions at the end of the call.
Before we begin, I would like to read the following regarding forward-looking statements. During the course of this conference call, the company may make projections or other forward-looking statements regarding future events or future business outlook, our development efforts and their outcome, our discovery platform, anticipated progress and timeline for our programs, financial and accounting related matters as well as statements regarding our cash position. We wish to caution you that such statements reflect only on the company s current expectations and that actual events or results may differ materially. You are kindly referred to the risk f ....

Henry Adewoye , Stephen Willey , Bristol Myers Squibb , Stephen Willey Stifel , Mark Breidenbach , Bristol Myers Squibbs , Exchange Commission , Mark Breidenbach Oppenheimer Co Analyst , Compugen Ltd , John Hopkins University , First Quarter , Anat Cohen Dayag , Ari Krashin , Chief Medical Officer , Chief Executive , Cancer Immunology , Drew Pardoll , Vice President , Chief Medical , ஸ்டீபன் வில்லி , பிரிஸ்டல் மைஸ் ஸ்க்விப்ப் , ஸ்டீபன் வில்லி ஸ்டிபேல் , குறி ப்ரீடன்பாக் , பரிமாற்றம் தரகு , ஜான் ஹாப்கின்ஸ் பல்கலைக்கழகம் , முதல் காலாண்டு ,

Exelixis Inc (EXEL) Q1 2021 Earnings Call Transcript


Operator
Good morning, ladies and gentlemen, and welcome to the Exelixis First Quarter 2021 Financial Results Conference Call. My name is Daphne, and I ll be your operator for today. As a reminder, this call is being recorded for replay purposes.
I would now like to turn the call over to your host for today, Ms. Susan Hubbard, Executive Vice President of Public Affairs and Investor Relations. Please proceed.
Susan T. Hubbard
Executive Vice President, Public Affairs and Investor Relations
Thank you, Daphne, and thank you all for joining us for the Exelixis First Quarter 2021 Financial Results Conference Call. Joining me on today s call are Mike Morrissey, our President and CEO; Chris Senner, our Chief Financial Officer; P.J. Haley, our Executive Vice President of Commercial; and Gisela Schwab, our Chief Medical Officer, who together will review our corporate, financial, commercial and development progress for the first quarter 2021 ended March 31, 2021. Peter ....

United States , Asthika Goodewarne , Andy Hsieh , Stephen Willey , Susan Hubbard , Stephen Willey Stifel , Jason Gerberry , Asthika Goodewarne Truist , Mike Morrissey , Andy Hsieh William Blair , Jay Olson Oppenheimer , Kennen Mackay , Peter Lawson , Michaelm Morrissey , Jay Olson , Yaron Werber , Christopherj Senner , Chris Senner , Akash Tewari , Giselam Schwab , Paul Choi Goldman Sachs , Michael Schmidt Guggenheim , Susant Hubbard , Gabe Daoud Cowen , Gisela Schwab , Paul Choi ,

Dicerna Pharmaceuticals Inc (DRNA) Q1 2021 Earnings Call Transcript


Operator
Good afternoon, ladies and gentlemen, and welcome to the Dicerna Pharmaceuticals First Quarter 2021 Earnings Conference Call. As a reminder, this conference call is being recorded at the company s request.
I will now turn the call over to your host, Will Grammig of Stern IR. Please go ahead.
Lauren Stival
Investor Relations
Thank you, operator. Good afternoon, everyone, and thank you for joining us to review Dicerna s first quarter 2021 financial results and operational highlights. For anyone who hasn t yet had a chance to review our results we issued a press release after the close of trading today, which is available under the investors and media tab on our website at dicerna.com. ....

United States , Robyn Karnauskas , Ed Arce , Doug Pagan , Henry Kranzler , Douglasw Pagan , Stephen Willey , Stephen Willey Stifel , Sheeram Aradhye , Mayank Mamtani , Smith Cowen , Rob Williams Goldman Sachs , Dicerna Gal , Rob Ciappenelli , Jim Weissman , Douglasm Fambrough , Yigal Nochomovitz , Robertd Ciappenelli , Yigal Nochomovitz Citigroup , Jonathan Miller Evercore , Shreeram Aradhye , Yaron Werber , Madhu Kumar , Bob Brown , Mani Foroohar , Jonathan Miller ,

GlycoMimetics Inc (GLYC) Q4 2020 Earnings Call Transcript


[Operator Instructions]
I would now like to turn the call over to Shari Annes of the Investor Relations group at GlycoMimetics. Please go ahead.
Shari Annes
Thank you. Good morning.
Today, we will review our accomplishments and financial results for both the three and 12-month periods ended December 31, 2020. We ll also update you on recent [Indecipherable]. The press release we issued this morning is available on the company s website at www.glycomimetics.com, under the Investors tab.
This call is being recorded. A dial-in phone replay will be available for 24 hours after the close of the call. The webcast replay will also be available on the Investor Relations section of the company s website for 30 days. ....

Shari Annes , Rachel King , Stephen Willey , Stephen Willey Stifel , Myra Rosario Herrle , Rachelk King , Zegbeh Jallah , Ericj Feldman , Helen Thackray , Biren Amin , Brian Hahn , John Magnani , Biren Amin Jefferies , Eric Feldman , Our Co , Regulatory Affairs , Md Anderson Cancer Center , Glycomimetics Inc , Department Of Leukemia , Duke University , Clinical Development , Society Of Hematologic Oncology , Investor Relations , Chief Executive Officer , Chief Financial , Chief Scientific Officer ,